Based on the unique clinical aspects of mutant CRT‐mediated MPNs and the distinct interactions that trigger cell transformation, a better understanding of the role of mutated CRT in the pathogenesis of MPNs could lead to new diagnostics and treatments for MPN patients with CALR mutations. The gene discussed is CALR; the disease is myeloproliferative neoplasm.